The effect of Allium porrum in the treatment of common warts.

Comparison of the efficacy of cryotherapy and hydroalcholic extract of the aerial parts of Allium porrum in the treatment of common warts.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016081629392N1

Enrollment

Registered

2017-03-22

Start date

2015-06-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

wart. Viral warts

Interventions

Intervention 1: The control group consisted of thirty patients with common warts on their hands who were treated with cryotherapy as a standard treatment. Patients were treated with cryotherapy once a

Treatment - Other

Treatment - Drugs

The control group consisted of thirty patients with common warts on their hands who were treated with cryotherapy as a standard treatment. Patients were treated with cryotherapy once a week for up to

The intervention group included thirty patients with common warts on their hands who were treated by topical application of the hydralcoholic extract of the aerial parts of Allium porrum L for up to

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All patients with common warts on the clinic of Medical Sciences in 94-95? written informed consent from patients for the study. Exclusion criteria: Pregnancy? breastfeeding the baby? a immunodeficiency disorders? progressive systemic diseases? blistering disorders, allergy history, treatment during recent 2 months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Warts's diameter. Timepoint: Baseline and every week to three weeks after intervention. Method of measurement: Ruler.	—

Secondary

Measure	Time frame
Pain. Timepoint: During treatment. Method of measurement: questionnaire.;Hypopigmentation. Timepoint: End of treatment. Method of measurement: Questionnaire and examination.;Hyperpigmentation. Timepoint: end of treatment. Method of measurement: Questionnaire and examination.;Blister. Timepoint: At the end of the treatment. Method of measurement: Questionnaire and examination.;Recurrence. Timepoint: end of treatment. Method of measurement: Questionnaire and examination.;Satisfaction. Timepoint: During and at the end of the treatment. Method of measurement: Questionnaire.	—

Measure

Time frame

Pain. Timepoint: During treatment. Method of measurement: questionnaire.;Hypopigmentation. Timepoint: End of treatment. Method of measurement: Questionnaire and examination.;Hyperpigmentation. Timepoint: end of treatment. Method of measurement: Questionnaire and examination.;Blister. Timepoint: At the end of the treatment. Method of measurement: Questionnaire and examination.;Recurrence. Timepoint: end of treatment. Method of measurement: Questionnaire and examination.;Satisfaction. Timepoint: During and at the end of the treatment. Method of measurement: Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Hamid Hamidi

Arak University of Medical Sciences

hamidhamidi432@gmail.com; h.hamidi@arakmu.ac.ir+98 86 3417 3645

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026